Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC fraud and abuse. We believe that the payment prohibition for CPAP in this rule will be applied to a broader set of CPAP supplier relationships than would be prohibited under Stark. We here address additional CPAP supplier relationships that do not necessarily depend on a relationship with the beneficiary’s treating physician who makes a referral, for example, a relationship between a sleep test provider and a DME supplier when the provider of the sleep test is not the beneficiary’s treating physician who made the referral for the test. Comment: One commenter stated that this proposal is unlawful. First, the commenter stated that general rulemaking authority cannot support a “Stark-like” proposal such as the one under consideration. Further, the commenter states that the preamble lacks sufficient facts or data to support the statutory predicate under section 1871(a)(1) that the rule must be “necessary to carry out the administration” of the Medicare program. The commenter summarizes their concerns by stating that the general grant of rulemaking authority is not plenary. The commenter also stated that the rule is inconsistent with the Stark statute and it’s implementing regulations, which the commenter asserted would not preclude a physician from selling a CPAP device to his or her patient if the physician is enrolled 742

CMS-1403-FC as a DME supplier and personally furnishes all of the services associated with the provision of the CPAP. In addition, the commenter concludes that this rule is in direct contradiction to the Stark law because, unlike the Stark law, this rule does not contain an exception for referrals made by a physician who has an ownership or investment interest in a “rural provider.” Response: We do not agree. Our authority for promulgating this rule is supported by two different provisions in the Act. First, we believe that section 1871(a)(1) of the Act, which authorizes the Secretary to “prescribe such regulations as may be necessary to carry out the administration of the insurance programs under this title,” provides sufficient authority for this regulation. We believe that the prevention of fraud and abuse in the provision of CPAP devices is essential to the efficient administration of the Medicare program. While the use of unattended HSTs will provide more beneficiaries with access to diagnosis and treatment of OSA, we are concerned that the increased number of unattended HSTs will in turn increase the potential for a test provider’s affiliation with a CPAP supplier to lead to overutilization as we discussed above. We believe that the administration of the Medicare program includes a responsibility to protect the 743

<strong>CMS</strong>-1403-FC<br />

as a DME supplier and personally furnishes all of the<br />

services associated with the provision of the CPAP. In<br />

addition, the commenter concludes that this rule is in<br />

direct contradiction to the Stark law because, unlike the<br />

Stark law, this rule does not contain an exception for<br />

referrals made by a physician who <strong>has</strong> an ownership or<br />

investment interest in a “rural provider.”<br />

Response: We do not agree. Our authority for<br />

promulgating this rule is supported by two different<br />

provisions in the Act. First, we believe that section<br />

1871(a)(1) of the Act, which authorizes the Secretary to<br />

“prescribe such regulations as may be necessary to carry<br />

out the administration of the insurance programs under this<br />

title,” provides sufficient authority for this regulation.<br />

We believe that the prevention of fraud and abuse in the<br />

provision of CPAP devices is essential to the efficient<br />

administration of the Medicare program. While the use of<br />

unattended HSTs will provide more beneficiaries with access<br />

to diagnosis and treatment of OSA, we are concerned that<br />

the increased number of unattended HSTs will in turn<br />

increase the potential for a test provider’s affiliation<br />

with a CPAP supplier to lead to overutilization as we<br />

discussed above. We believe that the administration of the<br />

Medicare program includes a responsibility to protect the<br />

743

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!